Share the Video:

Psychedelic policy approaches: from the visionary to the pragmatic

Tatiana Quintana, Melissa Lavasani, Logan Davidson

Diverse contexts demand diverse strategies; this thought-provoking discussion will span from the grounded to the audacious, reflecting on how pragmatic frameworks for psychedelic policy reform have been imagined and actualized. Delve into demographic considerations, regulatory and legal challenges, and the evidence-based practices that inform these approaches. At the intersection of visionary ideals and practical solutions we can foster a nuanced understanding of how psychedelic policy can be adjusted in different policy environments.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Updates from leading statewide regulatory initiatives - Oregon

Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use, influencing drug policy reforms in eleven other states in 2023.

Angela E Albee, Sam Chapman

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Research and Science

Updates from leading statewide regulatory initiatives - Colorado

Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use. Leaders discuss challenges and lessons learned in implementation.

Rev Veronica Lightning Horse P…, Ean Seeb, Hadas Alterman

PS2023 Business Policy and Advocacy Psychedelic Science Research Research and Science Social and Cultural

Patents, commons, and innovation in psychedelic drug development

Universities and companies are claiming intellectual property on psychedelic compounds, sparking dialogue on how patents may impact innovation and access to care in the psychedelic ecosystem. Explore economic and cultural

Jonathan Sporn, Sisi Li, Graham Pechenik, Retsina Meyer, Anne Donohoe

PS2023 MDMA Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

Priorities for the next generation of psychedelic science

NIMH Director Joshua A. Gordon and trauma researcher Barbara O. Rothbaum discuss the current state and future directions of psychedelic research, emphasizing the need for deeper understanding and robust study

Joshua A Gordon

PS2023 Business Policy and Advocacy Psychedelic Science Research Research and Science

The state of the psychedelic sector

Hardman provides a quick overview of the emerging psychedelic sector, covering financial, research, and policy landscapes with data visuals. He also explores unanswered questions about the sector's future.

Josh Hardman

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science Resources for Therapists

The State of Psychedelic Research Since 2017

Drs. Summergrad and Insel reflect on the progress and remaining questions in psychedelic science since 2017. They delve into topics like efficacy, regulation, therapy, and provider experience.

Paul Summergrad, Tom Insel, Rachel Nuwer

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Building momentum for new state policy approaches

Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.

Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Psychedelic-AT Research and Science Social and Cultural

A Family Legacy: From a Mother to her Sons

Rick Doblin discusses growing up with the "queen of psychedelics", Rock and Cosmo's paths to this work, challenges of working with family, and their shared vision for the psychedelic renaissance.

Amanda Feilding, Rock Feilding-Mellen, Cosmo Fielding Mellen

PS2023 Policy and Advocacy Psychedelic Science Research Research and Science

A conversation with Carl Hart, Ph.D.

Carl Hart, Chair of Psychology at Columbia University, is a renowned neuropsychopharmacologist, author, and media personality known for challenging drug perceptions through research, books, and media appearances.

Carl Hart

Psychedelic policy approaches: from the visionary to the pragmatic

Become a MAPS Member with a monthly donation

Related Videos